Squarepoint Ops LLC Genprex, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.19 - $0.37 $22,379 - $43,580	117,786 New	117,786 $27,000
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $115,660 - $181,115	-37,190 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.66 - $7.67 $136,115 - $285,247	37,190 New	37,190 $160,000
Q4 2020 Feb 16, 2021	SELL	$3.03 - $5.51 $48,619 - $88,413	-16,046 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.9 - $4.29 $46,533 - $68,837	16,046 New	16,046 $54,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.